Navigation Links
Frost & Sullivan Honors Clinical Ink for Developing an eSource Platform that Streamlines Clinical Development
Date:9/3/2014

MOUNTAIN VIEW, Calif., Sept. 3, 2014 /PRNewswire/ -- Based on its recent analysis of the eClinical solutions market, Frost & Sullivan recognizes Clinical Ink with the 2014 North American eClinical Solutions Award for Entrepreneurial Company of the Year. The award recognizes Clinical Ink's innovative SureSource® platform -- the  first purpose-built eSource solution that captures data electronically at the point of care.

Each year, Frost & Sullivan presents this award to the company that has demonstrated excellence in devising a strong growth strategy and robustly implementing it. The recipient has shown strength in terms of innovation in products and technologies, leadership in customer value, as well as speed in response to market needs.  In short, the award looks at the emerging market players in the industry and recognizes best practices that are positioned to fundamentally impact the clinical development process.

"The intuitive SureSource platform offers the freedom to work without regard to connectivity, while allowing fast and secure electronic transmission of source documents and data," said Jennifer Lazar, Frost & Sullivan Global Program Director, Life Sciences. "Clinical Ink's client and user satisfaction has been extremely positive, with nearly 80 percent of users claiming that SureSource positively affected their clinical trial process and that they are eager to use it again."

Clinical Ink is well-positioned to realize the FDA's vision of eliminating paper in the clinical trial process (FDA's recently released eSource guidance clearly "promotes" and "encourages" capturing data electronically).  The SureSource platform has been used in more than 50 studies worldwide and early adoption metrics show dramatic reductions in critical timelines and the potential to reduce monitoring cost by up to 50 percent. 

Unlike existing electronic data capture (EDC) platforms, SureSource allows site users to immediately capture data during the subject visit, using a tablet equipped with custom-built electronic source (eSource) forms.  Reflecting the clinical workflow of sites, SureSource eSource forms look just like traditional paper source, but incorporate sophisticated data validations and safeguards to clean data at the time it is initially captured.  The clinical data is immediately available for real-time, remote review by sites, sponsors, and CROs – a dramatic improvement from the weeks/months it can take in the traditional EDC model.  

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.

About Clinical Ink

With offices in Winston-Salem, NC and Philadelphia, PA, Clinical Ink is an innovation-driven eSource solutions company committed to delivering technology that makes clinical research easier for sites, sponsors, subjects and regulators.  Developers of SureSource®, the first purpose-built eSource platform that provides cleaner data faster, Clinical Ink is dedicated to eliminating paper documents in clinical research.  Additional information about Clinical Ink is available at www.clinicalink.com or by calling toll-free 800-301-5033.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation

Contact:

Mireya Espinoza
P: 210.247.3870
F: 210.348.1003
E: mireya.espinoza@frost.com

Alicia Maguire
P: 336.464.0696
E: alicia.maguire@clinicalink.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors
2. Needle-Free Delivery Devices Shape the Future of Vaccines, Says Frost & Sullivan
3. Frost & Sullivan: Change in Demographics and Surge in Domestic Manufacturing Drive Asia-Pacific Medical Devices Market
4. Frost & Sullivan Applauds Volpara Solutions Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer
5. Frost & Sullivan: Multi-Modality Breast Imaging Systems Spur Innovations in Europe
6. Frost & Sullivan: Healthcare Investor Focus on Malaysia Grows, Bolstered by Government Support and Medical Tourism
7. Frost & Sullivan Recognizes Baxano Surgical as a Leader in MIS Spine Innovation
8. Frost & Sullivan Honors Vitro Biopharma for its Outstanding Technological Innovations and Business Strategy in the Stem Cell Tools Industry
9. Frost & Sullivan Applauds F Cubed for its Game-Changing MRSA Screener, the NESDEP IU
10. Frost & Sullivan Honors Mobius Imaging for Developing a Mobile 32-Slice CT Scanner, the Airo Mobile Intraoperative CT
11. Frost & Sullivan Applauds MobileHelp for its Targeted Supplies for the PERS Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... FRAMINGHAM, Mass. , Feb. 12, 2016   ... scheduled a conference call and webcast to discuss its ... December 31, 2015, on Thursday, February 25, 2016 at ... financial results prior to the conference call and webcast.  ... the company,s financial results, highlights from the fourth quarter ...
(Date:2/12/2016)...  Memorial Hermann Health System has teamed up with ... bring a one-of-a-kind experience to pediatric patients at ... as 360-degree video and Google Cardboard, Howard was able ... giving the patients and their families an unexpected, and ... on video . Memorial Hermann IRONMAN ...
(Date:2/12/2016)... SEOUL, South Korea , Feb. 12, 2016 ... today announced they will form a partnership to ... medicine in cancer. The goal of the collaboration ... with Macrogen,s high-throughput Next Generation Sequencing capabilities toward ... Laboratory Improvement Amendments (CLIA) of 1988 by the ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... 13, 2016 , ... Valentine’s Day is nearly upon us, and most singles ... great outfit, flawless hair, and a sparkling personality are all well and good, but ... night at home with Rover. (Actually, man’s best friend might not even want to ...
(Date:2/13/2016)... ... February 13, 2016 , ... Many individuals looking to lead a healthy lifestyle ... reasons. IsoPasta by Isolator Fitness has delved into this niche allowing those giving ... high-carb repercussions. IsoPasta has 30 grams of protein and only 7 grams of ...
(Date:2/13/2016)... ... February 13, 2016 , ... The producers of Enterprises TV are ... The increasingly modern world of instantaneous consumption proves very convenient for businesses. With new ... oil and coal, which pollutes our air, water, and soil. It can also threaten ...
(Date:2/13/2016)... ... February 13, 2016 , ... Christie Medical Holdings, Inc. presented ... a VeinViewer® Vision vein finder for the nursing school simulation lab. ... and draw blood, combining technology with traditional technique. , “VeinViewer is a wonderful ...
(Date:2/13/2016)... (PRWEB) , ... February 13, 2016 , ... In the ... forward. They’ll groom themselves to perfection, go out of their way to be romantic, ... – just take a look at any online dating profile. , A recent ...
Breaking Medicine News(10 mins):